Table 3. Remission of comorbidities at 3-year follow-up.
| Comorbidities | LRYGB | LSG | P value | ||
|---|---|---|---|---|---|
| Preoperative | Resolution or improvement (%) | Preoperative | Resolution or improvement (%) | ||
| T2DM | 19 | 12 (63.2) | 14 | 8 (57.1) | 0.73 |
| Hypertension | 14 | 5 (35.7) | 16 | 4 (25.0) | 0.52 a |
| Dyslipidemia | 33 | 17 (51.5) | 32 | 18 (56.3) | 0.70 |
| Hyperuricemia | 9 | 3 (33.3) | 11 | 2 (18.2) | 0.62 a |
| Sleep apnea | 13 | 7 (53.8) | 18 | 8 (44.4) | 0.61 |
LRYGB: laparoscopic Roux-en-Y gastric bypass; LSG: laparoscopic sleeve gastrectomy; T2DM: type 2 diabetes mellitus.
a
Fisher's exact test (two-sided).